BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parker RB, Hu ZY, Meibohm B, Laizure SC. Effects of alcohol on human carboxylesterase drug metabolism. Clin Pharmacokinet 2015;54:627-38. [PMID: 25511794 DOI: 10.1007/s40262-014-0226-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Pesic M, Stöhr T, Ossig J, Borkett K, Donsbach M, Dao VA, Webster L, Schippers F. Remimazolam Has Low Oral Bioavailability and No Potential for Misuse in Drug-Facilitated Sexual Assaults, with or Without Alcohol: Results from Two Randomised Clinical Trials. Drugs R D 2020;20:267-77. [PMID: 32757149 DOI: 10.1007/s40268-020-00317-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
2 Her L, Zhu HJ. Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators. Drug Metab Dispos 2020;48:230-44. [PMID: 31871135 DOI: 10.1124/dmd.119.089680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
3 Fu Q, Yang K, Hu R, Du Z, Hu C, Zhang X. Evaluation of the inhibition of human carboxylesterases (CESs) by the active ingredients from Schisandra chinensis. Xenobiotica 2019;49:1260-8. [DOI: 10.1080/00498254.2018.1548718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Laizure SC, Hu Z, Potter PM, Parker RB. Inhibition of carboxylesterase-1 alters clopidogrel metabolism and disposition. Xenobiotica 2020;50:245-51. [DOI: 10.1080/00498254.2019.1612535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Myers AL. Metabolism of the areca alkaloids - toxic and psychoactive constituents of the areca (betel) nut. Drug Metab Rev 2022;:1-33. [PMID: 35543097 DOI: 10.1080/03602532.2022.2075010] [Reference Citation Analysis]
6 Gong X, Zhang Q, Ruan Y, Hu M, Liu Z, Gong L. Chronic Alcohol Consumption Increased Bile Acid Levels in Enterohepatic Circulation and Reduced Efficacy of Irinotecan. Alcohol Alcohol 2020;55:264-77. [PMID: 32232424 DOI: 10.1093/alcalc/agaa005] [Reference Citation Analysis]
7 Russo NW, Petrucci G, Rocca B. Aspirin, stroke and drug-drug interactions. Vascular Pharmacology 2016;87:14-22. [DOI: 10.1016/j.vph.2016.10.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
8 Hines RN, Simpson PM, McCarver DG. Age-Dependent Human Hepatic Carboxylesterase 1 (CES1) and Carboxylesterase 2 (CES2) Postnatal Ontogeny. Drug Metab Dispos 2016;44:959-66. [PMID: 26825642 DOI: 10.1124/dmd.115.068957] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
9 Traccis F, Presciuttini R, Pani PP, Sinclair JMA, Leggio L, Agabio R. Alcohol-medication interactions: A systematic review and meta-analysis of placebo-controlled trials. Neurosci Biobehav Rev 2021;132:519-41. [PMID: 34826511 DOI: 10.1016/j.neubiorev.2021.11.019] [Reference Citation Analysis]
10 Lv X, Wang D, Feng L, Wang P, Zou L, Hao D, Hou J, Cui J, Ge G, Yang L. A highly selective marker reaction for measuring the activity of human carboxylesterase 1 in complex biological samples. RSC Adv 2016;6:4302-9. [DOI: 10.1039/c5ra23614b] [Cited by in Crossref: 19] [Article Influence: 3.2] [Reference Citation Analysis]
11 Wang Z, Fong CY, Goh EML, Moy HY, Chan ECY. Transesterification of Indazole-3-Carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarker for Diagnosing Co-Abuse of 5F-MDMB-PINACA and Alcohol. J Anal Toxicol 2021:bkab121. [PMID: 34918103 DOI: 10.1093/jat/bkab121] [Reference Citation Analysis]
12 Jia Y, Ge P, Zhou H, Ji J, Tai T, Gu T, Zhu T, Li Y, Mi Q, Huang B, Xie H. Vicagrel enhances aspirin-induced inhibition of both platelet aggregation and thrombus formation in rodents due to its decreased metabolic inactivation. Biomedicine & Pharmacotherapy 2019;115:108906. [DOI: 10.1016/j.biopha.2019.108906] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Jia Y, Gu T, Ji J, Tai T, Zhang M, Huang B, Zhou H, Mi Q, Xie H. Aspirin Attenuates the Bioactivation of and Platelet Response to Vicagrel in Mice. Journal of Cardiovascular Pharmacology 2018;72:252-8. [DOI: 10.1097/fjc.0000000000000622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Qian Y, Gilliland TK, Markowitz JS. The influence of carboxylesterase 1 polymorphism and cannabidiol on the hepatic metabolism of heroin. Chem Biol Interact 2020;316:108914. [PMID: 31837295 DOI: 10.1016/j.cbi.2019.108914] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
15 Zhu HJ, Patrick KS, Straughn AB, Reeves OT 3rd, Bernstein H, Shi J, Johnson HJ, Knight JM, Smith AT, Malcolm RJ, Markowitz JS. Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers. J Clin Psychopharmacol 2017;37:419-28. [PMID: 28590363 DOI: 10.1097/JCP.0000000000000721] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
16 Ge PX, Jiang LP, Tai T, Zhu T, Ji JZ, Li YF, Mi QY, Xie HG. Short-term standard alcohol consumption enhances platelet response to clopidogrel through inhibition of Nrf2/Ces1 pathway and induction of Cyp2c in mice. Life Sci 2021;279:119268. [PMID: 33626394 DOI: 10.1016/j.lfs.2021.119268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Schrom K, Pacifico A, Conic RRZ, Pigatto PDM, Malagoli P, Morrone A, Finelli R, Bragazzi NL, Damiani G. Dabigatran-associated Acute Generalized Exanthematous Pustulosis (AGEP) in a psoriatic patient undergoing Ixekizumab and its pathogenetic mechanism. Dermatol Ther 2019;32:e13018. [PMID: 31286621 DOI: 10.1111/dth.13018] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Singh A, Gao M, Beck MW. Human carboxylesterases and fluorescent probes to image their activity in live cells. RSC Med Chem 2021;12:1142-53. [PMID: 34355180 DOI: 10.1039/d1md00073j] [Reference Citation Analysis]
19 Qian Y, Markowitz JS. Natural Products as Modulators of CES1 Activity. Drug Metab Dispos 2020;48:993-1007. [PMID: 32591414 DOI: 10.1124/dmd.120.000065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Wang D, Zou L, Jin Q, Hou J, Ge G, Yang L. Recent progress in the discovery of natural inhibitors against human carboxylesterases. Fitoterapia 2017;117:84-95. [DOI: 10.1016/j.fitote.2017.01.010] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 10.8] [Reference Citation Analysis]
21 Rudolph S, Dahlhaus H, Hanekamp W, Albers C, Barth M, Michels G, Friedrich D, Lehr M. Aryl N-[ω-(6-Fluoroindol-1-yl)alkyl]carbamates as Inhibitors of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and Butyrylcholinesterase: Structure-Activity Relationships and Hydrolytic Stability. ACS Omega 2021;6:13466-83. [PMID: 34056494 DOI: 10.1021/acsomega.1c01699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
22 Di L. The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics. Curr Drug Metab 2019;20:91-102. [PMID: 30129408 DOI: 10.2174/1389200219666180821094502] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 15.3] [Reference Citation Analysis]
23 Song Y, Weng Z, Dou T, Finel M, Wang Y, Ding L, Jin Q, Wang D, Fang S, Cao Y, Hou J, Ge G. Inhibition of human carboxylesterases by magnolol: Kinetic analyses and mechanism. Chemico-Biological Interactions 2019;308:339-49. [DOI: 10.1016/j.cbi.2019.06.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
24 Kilpatrick GJ. Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent. Front Pharmacol 2021;12:690875. [PMID: 34354587 DOI: 10.3389/fphar.2021.690875] [Reference Citation Analysis]
25 Xiao J, Shi J, Thompson BR, Smith DE, Zhang T, Zhu H. Physiologically-based pharmacokinetic modeling to predict methylphenidate exposure affected by interplay among carboxylesterase 1 pharmacogenetics, drug-drug interactions, and sex. Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.xphs.2022.04.019] [Reference Citation Analysis]